The event is held by the International Diabetes Federation (IDF), which unites 230 diabetes organizations from 130 countries of the world and is the main global platform dedicated to the current problems of diabetes treatment.

CheckEye is a Ukrainian IT startup that uses the capabilities of artificial intelligence to detect diabetic retinopathy in the early stages using photographic images of the fundus.

Photographs can be taken anywhere from optical shops to pharmacies by non-medical staff to be uploaded into the system for diagnosis.

Diabetic retinopathy is a disease that is the main cause of vision loss and one of the most common complications that occurs in almost 90% of patients with diabetes.

Early diagnosis will help minimize the number of cases of the disease and preserve vision in people with diabetes.

The problem of the spread of diabetes is extremely urgent for Ukraine.

According to the latest data from the Ministry of Health, 1.5 million Ukrainians have been officially diagnosed with diabetes.

But the real number is much higher - according to MDF data, every second diabetic patient has no idea about his diagnosis.

Thus, according to the diabetes atlas of Ukraine, there are about 2.3 million diabetic patients in Ukraine today.

The problem of the spread of the disease is expected to take on a pandemic character with an increase in the level of stress against the background of the deployment of full-scale military operations on the territory of the state.

Irregular passing of the necessary screenings, lack of proper medical care and treatment will lead to more cases of vision loss due to diabetic retinopathy.

According to the American Veterans Association, the prevalence of diabetes among people who have gone through war is three times higher than normal.

When extrapolating statistics to Ukrainian society, it is difficult to imagine the extent of the spread of the disease among the population and its consequences.

The innovative solution from CheckEye is aimed at simplifying the process of diagnosing diabetic retinopathy for both the doctor and the patient, while achieving a high level of accuracy of the results.

CheckEye's technology is based on the quality standards of the British Diabetic Retinopathy Screening Programme, where the main indicators are 80% accuracy in diagnosing the disease and 95% accuracy in determining the stage, with a waiting period of six weeks.

According to the results of the examination of the first 200 patients, the accuracy of the diagnosis with the help of artificial intelligence CheckEye is 92% and 82%, respectively, and the waiting time is 1 hour.

An innovative approach in the field of diagnostics is already available in Ukraine.

The CheckEye team in partnership with the Ukrainian Diabetes Federation and the Institute of Eye Diseases and Tissue Therapy named after

V.P.

Filatova organized a free mass screening for people with diabetes in the Chernivtsi region.

Screening began in October 2022 and is ongoing.

You can sign up for it on the CheckEye website - https://check-eye.com/uk/zapis-na-bezkoshtovnij-skrining/

In general, CheckEye, in cooperation with partners, plans to conduct free mass screening with the involvement of AI for more than 20,000 patients in settlements of at least 3 regions of Ukraine.